BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29367767)

  • 1. A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.
    Fantini D; Glaser AP; Rimar KJ; Wang Y; Schipma M; Varghese N; Rademaker A; Behdad A; Yellapa A; Yu Y; Sze CC; Wang L; Zhao Z; Crawford SE; Hu D; Licht JD; Collings CK; Bartom E; Theodorescu D; Shilatifard A; Meeks JJ
    Oncogene; 2018 Apr; 37(14):1911-1925. PubMed ID: 29367767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder.
    Masuda N; Murakami K; Kita Y; Hamada A; Kamada M; Teramoto Y; Sakatani T; Matsumoto K; Sano T; Saito R; Okuno Y; Ogawa O; Kobayashi T
    Am J Pathol; 2020 Aug; 190(8):1752-1762. PubMed ID: 32339497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice.
    Degoricija M; Korac-Prlic J; Vilovic K; Ivanisevic T; Haupt B; Palada V; Petkovic M; Karaman I; Terzic J
    J Transl Med; 2019 Nov; 17(1):394. PubMed ID: 31779626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
    Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
    Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
    Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
    Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
    Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards.
    Al-Kashwan TA; Houshmand M; Al-Janabi A; Melconian AK; Al-Abbasi D; Al-Musawi MN; Rostami M; Yasseen AA
    BMC Res Notes; 2012 Aug; 5():466. PubMed ID: 22929185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BBN-driven urinary bladder cancer mouse model.
    Korac-Prlic J; Degoricija M; Vilović K; Vujević S; Terzić J
    Methods Cell Biol; 2021; 163():77-92. PubMed ID: 33785170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic instability and p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Chen T; Murai T; Mori S; Morimura K; Oohara T; Makino S; Tatematsu M; Wanibuchi H; Fukushima S
    Carcinogenesis; 1997 Oct; 18(10):1877-82. PubMed ID: 9363994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression in the bladder carcinoma rat model.
    Ariel I; Ayesh S; Gofrit O; Ayesh B; Abdul-Ghani R; Pizov G; Smith Y; Sidi AA; Birman T; Schneider T; de Groot N; Hochberg A
    Mol Carcinog; 2004 Oct; 41(2):69-76. PubMed ID: 15378645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development.
    Vang DP; Wurz GT; Griffey SM; Kao CJ; Gutierrez AM; Hanson GK; Wolf M; DeGregorio MW
    J Vis Exp; 2013 Oct; (80):e50868. PubMed ID: 24300078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Elkin M; Ayesh S; Schneider T; de Groot N; Hochberg A; Ariel I
    Carcinogenesis; 1998 Dec; 19(12):2095-9. PubMed ID: 9886562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Animal models of bladder cancer].
    Fukushima S
    Hinyokika Kiyo; 1988 Nov; 34(11):1923-7. PubMed ID: 3242366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular credentialing of rodent bladder carcinogenesis models.
    Williams PD; Lee JK; Theodorescu D
    Neoplasia; 2008 Aug; 10(8):838-46. PubMed ID: 18670642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.
    Shi MJ; Fontugne J; Moreno-Vega A; Meng XY; Groeneveld C; Dufour F; Kamoun A; Viborg Lindskrog S; Cabel L; Krucker C; Rapinat A; Dunois-Larde C; Lepage ML; Chapeaublanc E; Levrel O; Dixon V; Lebret T; Almeida A; De Reynies A; Rochel N; Dyrskjøt L; Allory Y; Radvanyi F; Bernard-Pierrot I
    Eur Urol; 2023 Jan; 83(1):70-81. PubMed ID: 36273937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N-(-4-hydroxybutyl)nitrosamine: establishment of cell line, Nara Bladder Tumor II.
    Toyoshima K; Ito N; Hiasa Y; Kamamoto Y; Makiura S
    J Natl Cancer Inst; 1971 Nov; 47(5):979-85. PubMed ID: 4941696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.